Lucero aims to create a platform that enables high-throughput screening for metabolic profiling using hepatocyte spheroids.
With their system, scientists will be able to implement hepatocyte spheroids at scale in order to gather more patient-relevant data to make quicker pipeline decisions regarding the safety and efficacy of new compounds.